COMMON STOCK PURCHASE WARRANT ZYVERSA THERAPEUTICS, INC.ZyVersa Therapeutics, Inc. • February 13th, 2023 • Pharmaceutical preparations
Company FiledFebruary 13th, 2023 IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times on or after February [●], 2023 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from ZyVersa Therapeutics, Inc., a Delaware corporation (the “Company”), up to [●] shares of common stock, par value $0.0001 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 13th, 2023 • ZyVersa Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 13th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February [●], 2023, between ZyVersa Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Attn: Chief Executive Officer ZyVersa Therapeutics, Inc.ZyVersa Therapeutics, Inc. • February 13th, 2023 • Pharmaceutical preparations • New York
Company FiledFebruary 13th, 2023 Industry Jurisdiction